List of Vogelxo drug patents

Vogelxo is owned by Upsher Smith Labs.

Vogelxo contains Testosterone.

Vogelxo has a total of 3 drug patents out of which 0 drug patents have expired.

Vogelxo was authorised for market use on 04 June, 2014.

Vogelxo is available in gel;transdermal, gel, metered;transdermal dosage forms.

Vogelxo can be used as method for transdermal delivery of testosterone.

The generics of Vogelxo are possible to be released after 11 February, 2034.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8785426 UPSHER SMITH LABS Testosterone gel compositions and related methods
Feb, 2034

(11 years from now)

US9662340 UPSHER SMITH LABS Testosterone gel compositions and related methods
Feb, 2034

(11 years from now)

US9295675 UPSHER SMITH LABS Testosterone gel compositions and related methods
Feb, 2034

(11 years from now)

Drugs and Companies using TESTOSTERONE ingredient

Market Authorisation Date: 04 June, 2014

Treatment: Method for transdermal delivery of testosterone

Dosage: GEL, METERED;TRANSDERMAL; GEL;TRANSDERMAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in